Skip to main content

Table 2 Methodological characteristics of clinical trials

From: Androgenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic review

Author Year Rand. Alloc. Blind. Desc. losses Sample Size ITT Multic. Sponsor
Zagars 1988 NS NS No Yes No No No Public
Laverdiere 2004 NS NS No No No Ns No NS
Lawton 2005 Yes Yes No Yes Yes No Yes NS
Granfors 2006 NS NS No Yes Yes Yes No Public
See 2006 Yes Yes Yes Yes Yes Yes Yes Industry
D'Amico 2008 Yes Yes No Yes Yes Yes Yes Public
Roach 2008 NS NS No Yes Yes Yes Yes Public
Bolla 2010 Yes Yes No Yes Yes Yes Yes Both
Denham 2011 Yes Yes No Yes Yes No No Both
Jones 2011 Yes Yes No Yes Yes Yes Yes Public
  1. Abbreviations: Alloc allocation concealment, Blind blinding, Desc. Losses description of losses to follow-up, ITT intention-to-treat analysis, Multic multicentric, NS not stated, Rand adequate randomization method, Sample Size adequate planning and calculation of sample size